According to Bloomberg News, Vinay Prasad, who oversees gene therapies at the FDA, said the plans will be published in early November. He foresees the approach sparking curiosity for the next wave of ...

The press release will be available in the Investors section of Cellectis’ website: Cellectis will not host a conference call to discuss these results. Our investors relations team remains available ...

A U.S. regulator reportedly plans to unveil a faster approach to approving custom gene-editing treatments for rare diseases.

Therapeutics Startup Helex Secures USD 3.5 Mn to Develop Targeted Kidney Treatments Helex, a therapeutics startup focused on genetic kidney diseases, has raised USD 3.5 million in a seed funding round ...

Mary E. Brunkow Ph.D., a 1983 graduate of UW who now works in Seattle, won the Nobel Prize in Physiology or Medicine. News of ...

Title: Cibus, Inc. Third Quarter 2025 Results Conference Call Event Date: Thursday, November 13, 2025 Time: 4:30 p.m. ET Participant Numbers: +1-800-274-8461 (U.S.), +1-203-518-9814 (International) ...

Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, cirrhosis, or liver cancer and for development of future cell therapies.

Press Democrat readers share their thoughts on the president, the federal shutdown, resistance movements and Democrats ...

Organoids, three-dimensional cultures derived from stem cells, have rapidly emerged as a transformative technology within biomedical research. By closely ...

After two days full of live demos and pitches, it's time to announce the five finalists at this year's Startup Battlefield.

Because the new method can replace a large stretch of defective DNA with a healthy sequence, the same retron-based package can fix any combination of mutations within that stretch of DNA without ...

Biotech company Metagenomi ( NASDAQ: MGX) is utilizing artificial intelligence chips from Amazon Web Services ( AMZN) to ...